InsiderTrades.com logo
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>
Charles R. Gordon net worth and biography
  • LinkedIn
  • Phone
  • Website

Charles Gordon Biography and Net Worth

CEO of Aegion
Charles R. Gordon serves as President, Chief Executive Officer, Director of the Company. Mr. Gordon has been our President and Chief Executive Officer since October 2014 and served as our interim Chief Executive Officer from May 2014 to October 2014. Previously, Mr. Gordon served as the Chief Executive Officer of Natural Systems Utilities, LLC, a distributed water infrastructure company, from February 2014 until being appointed our interim Chief Executive Officer in May 2014. Prior to Natural Systems Utilities, Mr. Gordon was President and Chief Operating Officer of Nuverra Environmental Solutions, Inc., a holding company formerly known as Heckmann Corporation that buys and builds companies in the water sector, from October 2010 until October 2013. Mr. Gordon was President and Chief Executive Officer of Siemens Water Technologies, a business unit of Siemens AG, a world leader in products, systems and services for water and wastewater treatment for industrial, institutional and municipal customers, from 2008 to 2010. Previously, Mr. Gordon served as Executive Vice President of the Siemens Water & Wastewater Systems Group from 2005 to 2008 and as Executive Vice President of the Siemens Water & Wastewater Services and Products Group from 2003 to 2005. His past experience also includes various management positions with US Filter Corporation and Arrowhead Industrial Water, prior to the acquisition of US Filter Corporation by the Siemens family of companies in 2004. Mr. Gordon is a member of our Strategic Planning and Finance Committee.

What is Charles R. Gordon's net worth?

The estimated net worth of Charles R. Gordon is at least $8.20 million as of March 15th, 2021. Mr. Gordon owns 273,451 shares of Aegion stock worth more than $8,200,795 as of April 19th. This net worth evaluation does not reflect any other investments that Mr. Gordon may own. Additionally, Mr. Gordon receives a salary of $938,670.00 as CEO at Aegion. Learn More about Charles R. Gordon's net worth.

How old is Charles R. Gordon?

Mr. Gordon is currently 63 years old. There are 4 older executives and no younger executives at Aegion. Learn More on Charles R. Gordon's age.

What is Charles R. Gordon's salary?

As the CEO of Aegion Co., Mr. Gordon earns $938,670.00 per year. Learn More on Charles R. Gordon's salary.

How do I contact Charles R. Gordon?

The corporate mailing address for Mr. Gordon and other Aegion executives is 17988 EDISON AVENUE, CHESTERFIELD MO, 63005. Aegion can also be reached via phone at 636-530-8000. Learn More on Charles R. Gordon's contact information.

Has Charles R. Gordon been buying or selling shares of Aegion?

Charles R. Gordon has not been actively trading shares of Aegion within the last three months. Most recently, Charles R. Gordon sold 50,000 shares of the business's stock in a transaction on Monday, March 15th. The shares were sold at an average price of $27.81, for a transaction totalling $1,390,500.00. Following the completion of the sale, the chief executive officer now directly owns 273,451 shares of the company's stock, valued at $7,604,672.31. Learn More on Charles R. Gordon's trading history.

Charles R. Gordon Insider Trading History at Aegion

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2021Sell50,000$27.81$1,390,500.00273,451View SEC Filing Icon  
9/2/2020Sell50,000$16.26$813,000.00331,364View SEC Filing Icon  
3/12/2018Sell20,000$23.36$467,200.00306,802View SEC Filing Icon  
4/6/2015Buy238$17.99$4,281.62View SEC Filing Icon  
10/31/2014Buy10,910$18.34$200,089.40View SEC Filing Icon  
See Full Table

Charles R. Gordon Buying and Selling Activity at Aegion

This chart shows Charles R Gordon's buying and selling at Aegion by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aegion Company Overview

Aegion logo
Aegion Corporation provides technologies to maintain, rehabilitate, and strengthen infrastructure in the United States, Canada, Europe, and internationally. It operates through two segments, Infrastructure Solutions and Corrosion Protection. The company offers various solutions for rehabilitating and maintaining aging or deteriorating infrastructure; protecting new infrastructure from corrosion and other threats; and providing integrated professional services in engineering, procurement, construction, maintenance, and turnaround services for oil and natural gas companies. Its solutions include rehabilitation of water and wastewater pipelines; fusible polyvinyl chloride products for rehabilitation and new installation; fiber reinforced polymer systems for rehabilitation and strengthening; cathodic protection for corrosion engineering control and infrastructure rehabilitation; pipe coatings for corrosion and thermal control and prevention; thermoplastic pipe lining for corrosion control, abrasion protection, and pipeline rehabilitation; and construction and maintenance of oil and gas facilities. The company serves municipal, state, and federal governments, as well as corporate customers in various industries, including pipelines, energy, oil and gas, refinery, mining, general and industrial construction, infrastructure, water and wastewater, transportation, utilities, maritime, and defense. Aegion Corporation was founded in 1971 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $29.99
Low: $29.99
High: $29.99

50 Day Range

MA: $30.03
Low: $28.45
High: $30.79

2 Week Range

Now: $29.99
Low: $11.97
High: $30.95

Volume

N/A

Average Volume

327,389 shs

Market Capitalization

$922.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>